{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibfybidfplze6vt23recc5s67p2w5dygujojokyayaadppcfhne5m",
    "uri": "at://did:plc:6pwit4ctv4egvys3qyqmgbi6/app.bsky.feed.post/3mmeclxcfthy2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreieeou37jzej5eapeux44ohkotg64gdulkyl3xumlh2lucuyamyrre"
    },
    "mimeType": "image/webp",
    "size": 8966
  },
  "path": "/health/wild-west-peptide-craze-surges-beyond-glp-1s-fda-faces-pressure-ease-access",
  "publishedAt": "2026-05-21T11:00:57.000Z",
  "site": "https://www.foxnews.com",
  "tags": [
    "51243f73-e34f-5ecb-ad63-c3edad617198",
    "fnc",
    "Fox News",
    "fox-news/health",
    "fox-news/health/nutrition-and-fitness/weight-loss",
    "fox-news/health/medical-research",
    "fox-news/health/healthy-living/medications",
    "fox-news/lifestyle",
    "fox-news/health/nutrition-and-fitness/obesity",
    "article"
  ],
  "textContent": "The peptide market is surging alongside GLP-1 demand, creating tension between compounding pharmacies and commercial drug companies over patient access.",
  "title": "‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access"
}